June SCOUT? Report
Merit Medical Oncology
We're on a Mission to Ease the Burden Cancer Places on Patients and Their Loved Ones. #BreastSurgery #PatientCare
Gratitude to Our Partners for this Important Milestone…
Over 550,000 patients have been treated with SCOUT? Radar Localization. We are honored to have helped make a difference in so many patients’ lives worldwide. We want to thank the physicians who partner with us with the?shared goal of a better patient experience.
SCOUT Bx is the world’s first wire-free breast localization solution that can be deployed at the time of stereotactic or MRI-guided biopsy, sparing breast surgical patients a redundant localization procedure and helping physicians and breast centers streamline care.
Users are finding added utility with SCOUT Bx to localize under MRI when identifying lesions best visualized under MRI guidance, such as large areas of DCIS, non-mass enhancement and lobular lesions (see image).
Clinical Corner
RADAR localization has been featured recently in several compelling studies from around the world, solidifying SCOUT’s position of the most clinically referenced wire-free localization device on the market.?
领英推荐
From Australia: Chris O’Brien Lifehouse “Radar localization of breast and axillary lesions with SCOUT: a prospective single institution pilot study”
Findings include 100 percent successful placement and retrieval, placement in breast and axilla for Targeted Axillary Dissection (including at time of biopsy) and very high levels of surgeon satisfaction. See study.
From the UK: The London Breast Institute “Evaluating Radar Reflector Localisation in Targeted Axillary Dissection in Patients Undergoing Neoadjuvant Systemic Therapy for Node-Positive Early Breast Cancer: A Systematic Review and Pooled Analysis”
Findings conclude “Radar Reflector Localization is a highly reliable and accurate technique for localising pathological axillary lymph nodes in patients undergoing NST for early breast cancer. It facilitates the safe de-escalation of axillary surgery, reducing morbidity and improving quality of life without compromising oncological outcomes.” See Study.
From the US: Moffitt Cancer Center “Radar-Guided Localization and Resection for Metastatic Nodal and Soft Tissue Melanoma: A Single-Institution Retrospective Study”
Findings conclude “Radar Guided Localization is a safe and effective surgical localization method for soft tissue and nodal melanoma metastases. The inert nature of the reflector enables implantation prior to neoadjuvant therapy with utility in index lymph node removal.” See study.
Education Corner
Merit partnered with the Society of Surgical Oncology (SSO) for a Premiere Industry Webinar earlier this year. SSO experts in breast and surgical oncology reviewed advanced applications of SCOUT? to include reflector placement at the time of biopsy, prior to neoadjuvant chemotherapy (breast and melanoma) and under MRI guidance.Merit partnered with the Society of Surgical Oncology (SSO) for a Premiere Industry Webinar earlier this year. SSO experts in breast and surgical oncology reviewed advanced applications of SCOUT? to include reflector placement at the time of biopsy, prior to neoadjuvant chemotherapy (breast and melanoma) and under MRI guidance
Merit Oncology, Franchise Vice President
9 个月550,000 cancer patient that avoided wire-localization. Amazing progress. Super proud of the Global Merit Oncology Team delivering on the mission to “reduce the burden cancer places on cancer patients and their families”. Let’s Go!